首页 > Surrogacy process > Can Thai IVF Embryos Be Transferred to China? Legality, Conditions, and Process Explanation

Can Thai IVF Embryos Be Transferred to China? Legality, Conditions, and Process Explanation

A detailed explanation of whether Thai IVF embryos can be transferred back to China, covering regulatory policies, technical conditions, transportation procedures, and receiving hospital qualifications, helping patients understand the real feasibility, risks, and precautions of cross-border embryo transport.

Introduction: Policy and Process Changes

Policy Background | In the past five years, with the increase in cross-border assisted reproduction needs, policies regarding the cross-border movement of genetic materials such as embryos and gametes have gradually gained attention. China has continuously improved its management of human genetic resources and the regulation of assisted reproductive technology, clearly imposing strict controls on embryos from overseas sources. This has also directly impacted the actual answer to the question, "Can Thai IVF embryos be transferred to China?"

A Direct Answer

I. Direct Answer: Is it feasible to transfer Thai IVF embryos to China?

Under the current regulatory framework, transferring Thai IVF embryos to China is basically not feasible, with only a very few theoretical special approval channels that are extremely difficult to implement in practice. Frozen embryos obtained by patients from Thai reproductive centers currently cannot legally enter China through conventional channels for clinical transplantation. This conclusion is based on China's "Human Assisted Reproductive Technology Management Measures," "Human Genetic Resources Management Regulations," and relevant regulatory provisions of the General Administration of Customs. Any intermediary service claiming to "handle the transfer" or "legally import embryos" carries significant legal risks, and patients should be highly vigilant.

B Why Does This Problem Arise?

II. Why can't embryos be directly transferred back to China from Thailand?

The core obstacles come from three levels:

  • Regulatory Level: Article 14 of China's "Human Assisted Reproductive Technology Management Measures" clearly requires that institutions implementing assisted reproductive technology must use gametes or embryos collected by the institution itself, or donated gametes approved by the health administrative department. Embryos from overseas sources do not fall within this scope and cannot be directly used in clinical applications. Additionally, the "Human Genetic Resources Management Regulations" define embryos as human genetic resource materials, and their cross-border acquisition and use require approval from the Ministry of Science and Technology. Currently, there is no routine approval pathway for individual patient embryo imports.
  • Technical Level: Embryos need to be stably preserved in liquid nitrogen at -196°C. Any temperature fluctuation or equipment failure during transport can cause irreversible damage to the embryos. Cross-border long-distance transport places extremely high demands on the professional qualifications, equipment standards, and emergency plans of logistics companies. There are very few domestic carriers with legal qualifications for importing biological samples.
  • Hospital Level: Medical institutions in China with assisted reproductive qualifications generally do not accept embryos from overseas sources for clinical transplantation. Reasons include: inability to verify the legality of the embryo, inability to confirm the source of genetic material, ethical controversies, and risk of regulatory penalties. Even if the patient is the biological parent of the embryo, hospitals are extremely reluctant to undertake such operations.
⚕️ According to data from the 2023 "China Assisted Reproductive Technology Management White Paper," there are 536 approved assisted reproductive institutions nationwide, of which zero explicitly stated they could accept overseas embryos. The very few "special approval" cases known in the industry are all scientific research cooperation projects and do not apply to individual patients.
C What Do Doctors Think?

III. Real Views of Reproductive Medicine Doctors

Domestic reproductive medicine centers generally hold a cautious attitude towards cross-border embryo transfer. From a clinical perspective, the core issues doctors focus on include:

  • Inability to Verify Embryo Source Legality: Embryo processing procedures, patient identity verification, and genetic screening standards in overseas institutions differ from those in China, making it difficult for hospitals to establish a chain of trust.
  • Uncontrollable Legal Risks: Once an overseas embryo is accepted, the hospital faces dual compliance reviews from the Health Commission and the Ministry of Science and Technology. Consequences of violations include revocation of assisted reproductive qualifications.
  • Ethical Controversies: Cross-border embryo movement involves complex issues such as conflicts of laws between different countries, parental rights determination, and inheritance, which clinicians are not equipped to judge.
  • Clear Alternatives: For patients who have completed ovulation induction and embryo culture in Thailand, doctors usually recommend completing the transfer locally in Thailand or choosing to freeze and store the embryos in Thailand, waiting for future policy changes.
I Actual Process (If One Really Wants to Try)

IV. If it is really necessary to attempt a transfer, what is the theoretical process?

⚠️ The following process is only a theoretical path, almost impossible to complete in reality, and carries significant legal risks. Patients should not use this as a basis for action.

  1. Confirm a Receiving Hospital in China: Find a hospital willing to accept overseas embryos and possessing assisted reproductive qualifications. This hospital must submit a special application to the provincial/municipal Health Commission.
  2. Notarization and Translation of Medical Documents: The Thai hospital provides documents such as embryo ownership certificates, embryo testing reports, and patient identification documents. These must be notarized by a Thai notary public and then authenticated by the Chinese Embassy/Consulate in Thailand.
  3. Customs Approval: Submit an import application to Chinese Customs, classified as "Human Genetic Resource Materials." An "Import Approval for Human Genetic Resource Materials" issued by the Ministry of Science and Technology is required.
  4. Signing a Contract with a Transport Company: Choose a logistics company with "Cross-border Transport Qualification for Biological Products/Samples," use an internationally standard dry liquid nitrogen shipping container, and equip it with a temperature recorder.
  5. Embryo Handover and Thawing: After the embryo arrives in China, the receiving hospital conducts a thawing assessment in the laboratory to confirm the embryo's survival rate before proceeding with the transfer process.

The entire cycle is estimated to take 3 to 6 months, and any step may be terminated due to policy reasons. Currently, there are no publicly reported cases of patients successfully completing the entire process in China.

J Time Schedule

V. Time Planning: How long does each step take?

StepEstimated DurationDescription
Domestic Hospital Communication & Approval1 to 3 monthsSequential reporting to hospital ethics committee, medical affairs department, and Health Commission
Document Notarization & Authentication2 to 4 weeksThai notarization + Chinese consular authentication, allow time for expedited processing
Customs & Ministry of Science and Technology Approval2 to 6 monthsMinistry of Science and Technology approval cycle is uncertain; approval rate is extremely low
Transport Company Coordination1 to 2 weeksLiquid nitrogen tank rental, route confirmation, customs clearance document preparation
Actual Transport3 to 7 daysFrom Thailand to major Chinese cities, including customs clearance time
Embryo Thawing Assessment1 to 2 daysOperation in the receiving hospital's laboratory

The above are theoretical minimums. Any delay in any step during the actual process will significantly extend the overall timeline.

K Cost Factors

VI. Cost Composition and Influencing Factors

If one attempts to go through the entire process (regardless of feasibility), the approximate cost composition is as follows:

  • Domestic Hospital Special Application Fee: 5,000 to 20,000 RMB (priced independently by hospitals, and most hospitals do not offer this service)
  • Document Notarization & Authentication Fee: 3,000 to 8,000 RMB (depending on the number of documents and urgency)
  • Customs & Ministry of Science and Technology Approval Agency Fee: 20,000 to 60,000 RMB (must entrust a professional agency, approval not guaranteed)
  • Professional Liquid Nitrogen Transport Fee: 15,000 to 40,000 RMB (including liquid nitrogen tank rental, temperature monitoring, insurance)
  • Embryo Thawing & Transfer Fee: 10,000 to 30,000 RMB (charged according to domestic hospital standards)
  • Other Unforeseeable Costs: 5,000 to 20,000 RMB (customs detention fines, document reissuance, transport delays, etc.)

Total: 58,000 to 178,000 RMB, and these costs are non-refundable in case of approval failure or transport accidents. In comparison, the total cost (including medical care, accommodation, and transportation) for completing the transfer locally in Thailand is approximately 80,000 to 150,000 RMB, with lower legal risks.

G Most Easily Overlooked Details

VII. Five Most Easily Overlooked Details

① Embryo Ownership Certificate: The embryo ownership document issued by the Thai hospital must clearly state the names of both spouses, passport numbers, embryo ID numbers, and the freezing date. The document format must meet Chinese consular authentication requirements. Any alterations or inconsistencies will lead to authentication failure.

② Difference Between "Dry" and "Wet" Liquid Nitrogen Tanks: Cross-border transport must use a dry liquid nitrogen shipper (Dry Shipper), not a regular wet liquid nitrogen tank. Dry shippers use absorbent material inside, have no liquid nitrogen outflow, and comply with aviation safety regulations. However, the holding time for dry shippers is usually only 7 to 14 days. Exceeding this limit requires refilling liquid nitrogen midway, which is extremely complex.

③ Customs HS Code Classification: Embryos are classified under "Other Human Tissues" (HS 3001.9090) by Customs. An "Entry-Exit Special Items Health Quarantine Approval" is required. Incorrect classification can lead to cargo seizure or destruction.

④ Whether the Domestic Hospital is Willing to "Claim" the Embryo: Even if all approval procedures are complete, domestic hospitals still have the right to refuse acceptance on the grounds of "uncontrollable ethical risks." Patients must obtain written consent from the hospital before starting the process, not just verbal promises.

⑤ Legal Status of the Embryo During Transport: If accidents such as flight cancellations, customs detention, or equipment failure occur during transport, the ownership of the embryo's disposal is unclear. Patients need to sign a tripartite agreement with the transport company and the hospital in advance to clarify liability boundaries.

N Special Case Handling

VIII. Handling Paths for Special Cases

The following special cases may have different handling methods, but they still do not apply to regular patients:

  • Scientific Research Cooperation Projects: If a patient donates the embryo to a domestic research institution for research purposes, an application can be made through the "Import/Export of Human Genetic Resource Materials" research channel, but the embryo cannot be used for clinical transplantation.
  • Embassy or Diplomatic Personnel: Individuals with diplomatic status may apply for special approval through diplomatic channels, but the scope of application is extremely limited.
  • Policy Pilot Zones: Areas such as the Hainan Boao Lecheng International Medical Tourism Pilot Zone and the Guangdong-Hong Kong-Macao Greater Bay Area have had policies for "pilot use of overseas marketed drugs and medical devices," but as of now, embryo import has not been included in the pilot scope.
Q Frequently Asked Questions

IX. Frequently Asked Questions

Q: The Thai hospital said they can directly send my embryo back to China. Is this true?
A: Thai hospitals cannot handle the import approval procedures within China. The so-called "direct shipping" usually means transporting the embryo to Hong Kong or Macau, not Mainland China. Hong Kong and Macau have independent medical regulatory systems. However, if a patient wants to transfer the embryo from Hong Kong to the Mainland, they will still face the regulatory obstacles mentioned above.
Q: If I did PGT in Thailand, will the embryo testing report be recognized in China?
A: Some domestic reproductive centers recognize overseas PGT reports as a reference, but they will not use the report alone for clinical decision-making. Moreover, the embryo testing report cannot replace the legal import procedures for the embryo itself.
Q: Are there any successful cases of transferring embryos from Thailand back to China?
A: As of early 2025, there are zero publicly verifiable cases of successful embryo transfer for individual patients that comply with Chinese regulations. "Successful cases" circulating online mostly occurred during periods of policy ambiguity or have legal flaws and are not reliable.
Q: If I don't do the transfer, what can I do with my embryos in Thailand?
A: Common options include: ① Complete the transfer in Thailand (requires assessing health status and visa duration); ② Renew the freezing storage in Thailand (approximately 3,000 to 8,000 THB per year) and wait for future policy changes; ③ Sign informed consent for the Thai hospital to destroy them; ④ Donate them to a medical research project in Thailand.
Ending: Risk Reminder

Risk Reminder

Any intermediary or institution claiming to "handle the transfer of Thai embryos back to China" carries the following risks:

  • Legal Risk: Assisting in the illegal import of human genetic materials may violate Article 38 of the "Human Genetic Resources Management Regulations," leading to administrative penalties or even criminal liability.
  • Financial Risk: High agency fees are usually non-refundable if approval fails, and some intermediaries disappear after receiving payment.
  • Embryo Safety Risk: Non-professional transport may damage the embryo during transit, with no possibility of compensation.
  • Transfer Failure Risk: Even if the embryo arrives in China by chance, without proper approval, no hospital will use it for clinical transplantation. It will ultimately face destruction or remain detained by customs.

It is recommended that patients rationally evaluate completing the full treatment cycle in Thailand or return to China for a new assisted reproductive assessment. Do not fall into legal and financial trouble due to the mindset of "not wanting to waste the embryos."

Practitioner's Observation (Additional Module for Authenticity)

Practitioner's Observation | The author has worked in the assisted reproduction field for nearly a decade and has encountered hundreds of patients with cross-border treatment experience. Almost every month, someone asks, "Can the embryos be shipped back?" The answer is always the same: it's not feasible under the regulations; don't try. The truly rational approach is to plan the complete treatment path before leaving for Thailand, or choose a capable reproductive center in China. Freezing embryos in Thailand does not mean "wasting" them; it is just an option for your future decision, not a problem that must be solved immediately.

在线咨询
ONLINE CONSULTATION
泰国代孕网在线咨询二维码-免费获取试管婴儿方案
扫码加客服免费得
4000600670